The iconic rise of copyright’s flagship product presented a significant prospect for the market, but its patent has ended, creating a complex landscape. Alternative versions have appeared in the arena, eroding revenues and putting a strain on profit yields. While established healthcare companies maintain a stake in this area, the future looks clo